Theoretically, hemoglobin variability in patients with CKD may originate from an altered rate of apoptosis of precursor cells within the proliferating compartment of the marrow(due to EPO deficiency), or it may occur due to an increased delay in cell maturation times within the marrow. Here, EPO is linked to hyperinsulinemic hypoglycemia, familial, 4.